Elekta’s leading cancer registry products, METRIQ® and Précis-Central™, increase productivity and improve data quality.
Elekta’s leading cancer registry products, METRIQ® and Précis-Central™, increase productivity and improve data quality.
These products meet regulatory reporting requirements and provide ready access to data required to effectively review, analyze and ultimately improve clinical outcomes.
The status of patients in the registry database is updated annually to provide information for survival and recurrent patterns for cancer programs, helps track patient status and matches with comprehensive national mortality listings. Timely, high quality updates ensure that METRIQ satisfies current regulatory reporting and accreditation requirements including ACoS, AJCC, NAACCR, NPCR, SEER national and state/provincial requirements as well as compliance with international
standards including ICD-10.